Cardiol Therapeutics Inc - Ordinary Shares - Class A

+0.29 (+8.01%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Cardiol Therapeutics Inc - Ordinary Shares - Class A Stock, NASDAQ:CRDL

2265 Upper Middle Road East, Suite 602, Oakville, Ontario L6H 0G5
Phone: +1.289.910.0850
Number of Employees: 14


Cardiol Therapeutics Inc. is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus. The company was founded by David Elsley, Eldon Smith, and Anthony Bolton on January 19, 2017 and is headquartered in Oakville, Canada.